Cambridge, MA, United States of America

Benjamin Thuronyi

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Benjamin Thuronyi in Genetic Editing

Introduction

Benjamin Thuronyi is an accomplished inventor based in Cambridge, MA. He is renowned for his contributions to the field of genetic editing, particularly through his groundbreaking patent that focuses on evolving base editors.

Latest Patents

Thuronyi holds a notable patent titled "Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)." This innovative specification presents evolved base editors that address common deficiencies found in existing technologies. Specifically, it highlights enhancements in efficiency and a reduced requirement for specific sequence-context at an editing site. The advancement stems from a PACE system, particularly focusing on developed cytidine base editors, including those based on APOBEC1, CDA, or AID cytidine deaminase domains.

Career Highlights

Throughout his career, Thuronyi has made significant strides in the biotechnology sector. He has been affiliated with prestigious institutions such as Harvard College and the Broad Institute, where he has worked on pioneering projects. His research aims to improve genetic editing tools, making them more efficient and versatile.

Collaborations

Benjamin has collaborated with notable professionals in the field, including Christopher Gerard Wilson. Such collaborations have fostered the exchange of ideas and advancements in genetic editing technologies, further establishing Thuronyi's reputation as an innovative force in biotechnology.

Conclusion

In summary, Benjamin Thuronyi's inventive spirit and scientific contributions have made a significant impact on genetic editing. His patent showcases a promise for the future in biotechnology and exemplifies the importance of continuous evolution in research. As he continues to work alongside esteemed institutions and fellow innovators, his work is expected to pave the way for advancements in genetic technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…